Hi JD
There are many companies following the virotherapy and CPI route. Have a look at Targovax CPI resistant melanoma results from last year (from memory 35% response rate treating failed cpi treated cases)
If you want more science have a look at this paper
https://www.cell.com/molecular-therapy-family/oncolytics/fulltext/S2372-7705(21)00024-3
specifically look at the response rate figure from the same model (B-16) that Race has used and compare the results. You will see there is complete inhibition of tumor growth and the activation of a systemic abscopal effect.
There are many other examples.
Ann: Zantrene Improves Immune Therapy Treatment of Melanoma, page-66
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.61 |
Change
-0.045(2.73%) |
Mkt cap ! $273.5M | |||
| Open | High | Low | Value | Volume |
| $1.66 | $1.66 | $1.61 | $159.4K | 98.03K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 5684 | $1.61 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.62 | 2000 | 1 |
View Market Depth
| Last trade - 16.10pm 08/10/2024 (20 minute delay) ? |
| RAC (ASX) Chart |